Table 3 Prognostic factors for BCSS and OS by multivariable proportional hazards regression.
Characteristics | BCSS | OS | ||
---|---|---|---|---|
HRs (95% CI) | P value | HRs (95% CI) | P value | |
Age (years) | ||||
< 49 | 1.00 | 1.00 | ||
50–64 | 1.24(0.90, 1.73) | 0.2 | 1.42(1.09, 1.85) | 0.01 |
> 65 | 1.82(1.29, 2.59) | < 0.001 | 3.19(2.47, 4.13) | < 0.001 |
Marital status | ||||
Single | 1.00 | 1.00 | ||
Married | 0.67(0.46, 0.98) | 0.037 | 0.54(0.42, 0.70) | < 0.001 |
DSW | 1.11(0.74, 1.67) | 0.6 | 1.09(0.83, 1.41) | 0.5 |
Income | ||||
<$75,000 | 1.00 | 1.00 | ||
>$75,000 | 0.92(0.70, 1.21) | 0.6 | 0.82(0.68, 0.98) | 0.031 |
Race | ||||
White | 1.00 | 1.00 | ||
Black | 1.29(0.88, 1.87) | 0.2 | 1.35(1.06, 1.72) | 0.016 |
Others | 0.61(0.37, 1.01) | 0.054 | 0.59(0.41, 0.84) | 0.003 |
Primary Site | ||||
Central portion | 1.00 | 1.00 | ||
Upper outer | 0.72(0.54, 0.96) | 0.023 | 0.84(0.70, 0.98) | 0.045 |
Other sites | 0.72(0.44, 1.20) | 0.2 | 1.18(0.90, 1.56) | 0.2 |
Histology | ||||
IDC | 1.00 | 1.00 | ||
ILC | 0.79(0.49, 1.26) | 0.3 | 0.96(0.72, 1.27) | 0.8 |
Others | 0.55(0.36, 0.84) | 0.006 | 0.86(0.68, 1.09) | 0.2 |
Grade | ||||
I | 1.00 | 1.00 | ||
II | 1.68(1.05, 2.69) | 0.031 | 1.16(0.91, 1.47) | 0.2 |
III | 2.96(1.75, 5.00) | < 0.001 | 1.69(1.27, 2.26) | < 0.001 |
T stage | ||||
T1 | 1.00 | 1.00 | ||
T2 | 1.47(1.14, 1.90) | 0.003 | 1.32(1.11, 1.56) | 0.002 |
Subtype | ||||
HR+/HER2- | 1.00 | 1.00 | ||
HR+/HER2+ | 0.63(0.38, 1.03) | 0.064 | 1.06(0.77, 1.44) | 0.7 |
HR-/HER2+ | 0.81(0.43, 1.52) | 0.5 | 0.95(0.58, 1.57) | 0.9 |
HR-/HER2- | 2.06(1.39, 3.06) | < 0.001 | 1.8(1.28, 2.53) | < 0.001 |
Number of metastatic sentinel-nodes | ||||
1 | 1.00 | 1.00 | ||
2 or 3 | 1.49(1.05, 2.11) | 0.025 | 1.34(1.05, 1.72) | 0.018 |
Chemotherapy | ||||
No | 1.00 | 1.00 | ||
Yes | 1.24(0.87, 1.76) | 0.2 | 0.73(0.59, 0.90) | 0.004 |
Surgery | ||||
Non-ALND | 1.00 | 1.00 | ||
ALND | 0.86(0.61, 1.02) | 0.069 | 0.86(0.73, 1.02) | 0.086 |